Victory Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,125
| Closed | -$14K | – | 3807 |
|
|
2019
Q4 | $14K | Hold |
4,125
| – | – | ﹤0.01% | 2619 |
|
|
2019
Q3 | $13K | Hold |
4,125
| – | – | ﹤0.01% | 3188 |
|
|
2019
Q2 | $10K | Hold |
4,125
| – | – | ﹤0.01% | 1811 |
|
|
2019
Q1 | $15K | Hold |
4,125
| – | – | ﹤0.01% | 1753 |
|
|
2018
Q4 | $15K | Hold |
4,125
| – | – | ﹤0.01% | 1751 |
|
|
2018
Q3 | $24K | Buy |
4,125
+542
| +15% | +$3.15K | ﹤0.01% | 1751 |
|
|
2018
Q2 | $18K | Hold |
3,583
| – | – | ﹤0.01% | 1801 |
|
|
2018
Q1 | $18K | Hold |
3,583
| – | – | ﹤0.01% | 1797 |
|
|
2017
Q4 | $22K | Sell |
3,583
-3,669
| -51% | -$22.5K | ﹤0.01% | 1782 |
|
|
2017
Q3 | $40K | Hold |
7,252
| – | – | ﹤0.01% | 1755 |
|
|
2017
Q2 | $34K | Buy |
7,252
+2,941
| +68% | +$13.8K | ﹤0.01% | 1750 |
|
|
2017
Q1 | $21K | Buy |
4,311
+2,313
| +116% | +$11.3K | ﹤0.01% | 1775 |
|
|
2016
Q4 | $22K | Buy |
1,998
+111
| +6% | +$1.22K | ﹤0.01% | 1755 |
|
|
2016
Q3 | $17K | Buy |
1,887
+127
| +7% | +$1.14K | ﹤0.01% | 1759 |
|
|
2016
Q2 | $11K | Buy |
1,760
+70
| +4% | +$438 | ﹤0.01% | 1621 |
|
|
2016
Q1 | $11K | Buy |
1,690
+132
| +8% | +$859 | ﹤0.01% | 1648 |
|
|
2015
Q4 | $13K | Buy |
1,558
+85
| +6% | +$709 | ﹤0.01% | 1665 |
|
|
2015
Q3 | $11K | Buy |
1,473
+131
| +10% | +$978 | ﹤0.01% | 1606 |
|
|
2015
Q2 | $14K | Buy |
+1,342
| New | +$14K | ﹤0.01% | 1612 |
|